Genetic Technologies to Wind Down U.S. ADR Program Amid ASX Trading SuspensionTip Ranks·Jun 21 at 07:42 PMGENE
11:40 ETLabGenomics Unifies QDx and IMD Under One Brandprnewswire·May 11 at 10:40 AMSBIO-0.88%PBE-0.38%
enGene Therapeutics Rebrands as Company Nears CommercializationTip Ranks·Apr 9 at 03:38 PMENGNW0.00%ARKG-2.60%
Availability of Transgene's 2025 Universal Registration Document (URD)Unusual Whales·Apr 9 at 11:05 AM2342GENE
Your Genetic Wellness Partners with Senior Care Expert Lance A. Slatton to Expand Reach of Actionable BiologyMorningStar·Apr 3 at 04:10 PMGENE
Genetic Technologies Stays Non‑Trading as Restructuring Under DOCA ContinuesTip Ranks·Mar 29 at 08:52 PMGENE
Genetic Technologies Director Musgrave Steps Down With No ShareholdingTip Ranks·Mar 26 at 08:12 PMGENE
Genetic Technologies Reshapes Board With New Director Appointments and ResignationsTip Ranks·Mar 24 at 02:03 AMGENE
Genetic Technologies Drops Wealth Firm Deal to Refocus on Relisting StrategyTip Ranks·Mar 23 at 08:42 PMGENE
Genedrive shareholders back fundraising as company expands pharmacogenetic footprintTip Ranks·Mar 9 at 06:33 AMGNCAQ0.00%GENE
21:00 ETGene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026prnewswire·Mar 3 at 08:00 PMGENEPBE-0.38%
